| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2819 | 2015 |
| Risk of prostate cancer–specific mortality following biochemical recurrence after radical prostatectomy SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, FJ Dorey, ... Jama 294 (4), 433-439, 2005 | 1719 | 2005 |
| Early detection of prostate cancer: AUA Guideline HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ... The Journal of urology 190 (2), 419-426, 2013 | 1483 | 2013 |
| Autonomic nerve development contributes to prostate cancer progression C Magnon, SJ Hall, J Lin, X Xue, L Gerber, SJ Freedland, PS Frenette Science 341 (6142), 1236361, 2013 | 1149 | 2013 |
| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ... The Journal of urology 199 (3), 683-690, 2018 | 943 | 2018 |
| Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy BJ Trock, M Han, SJ Freedland, EB Humphreys, TL DeWeese, AW Partin, ... Jama 299 (23), 2760-2769, 2008 | 801 | 2008 |
| Obesity and prostate cancer: weighing the evidence EH Allott, EM Masko, SJ Freedland European urology 63 (5), 800-809, 2013 | 758 | 2013 |
| Active surveillance for prostate cancer: a systematic review of the literature MA Dall’Era, PC Albertsen, C Bangma, PR Carroll, HB Carter, ... European urology 62 (6), 976-983, 2012 | 731 | 2012 |
| Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer NL Keating, AJ O'Malley, SJ Freedland, MR Smith Journal of the National Cancer Institute 102 (1), 39-46, 2010 | 646 | 2010 |
| Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort C Rodriguez, SJ Freedland, A Deka, EJ Jacobs, ML McCullough, ... Cancer Epidemiology Biomarkers & Prevention 16 (1), 63-69, 2007 | 464 | 2007 |
| The correlation between metabolic syndrome and prostatic diseases C De Nunzio, W Aronson, SJ Freedland, E Giovannucci, JK Parsons European urology 61 (3), 560-570, 2012 | 456 | 2012 |
| Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital … SJ Freedland, WJ Aronson, CJ Kane, JC Presti Jr, CL Amling, D Elashoff, ... Journal of Clinical Oncology 22 (3), 446-453, 2004 | 454 | 2004 |
| Epidemiology and prevention of prostate cancer G Gandaglia, R Leni, F Bray, N Fleshner, SJ Freedland, A Kibel, P Stattin, ... European urology oncology 4 (6), 877-892, 2021 | 452 | 2021 |
| Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology P Nuhn, JS De Bono, K Fizazi, SJ Freedland, M Grilli, PW Kantoff, ... European urology 75 (1), 88-99, 2019 | 448 | 2019 |
| Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer LL Banez, RJ Hamilton, AW Partin, RT Vollmer, L Sun, C Rodriguez, ... Jama 298 (19), 2275-2280, 2007 | 444 | 2007 |
| Association of black race with prostate cancer–specific and other-cause mortality RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ... JAMA oncology 5 (7), 975-983, 2019 | 419 | 2019 |
| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: recommended approaches and details of specific care options MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ... The Journal of urology 199 (4), 990-997, 2018 | 394 | 2018 |
| Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction LW Jones, ND Eves, M Haykowsky, SJ Freedland, JR Mackey The lancet oncology 10 (6), 598-605, 2009 | 383 | 2009 |
| The contemporary concept of significant versus insignificant prostate cancer G Ploussard, JI Epstein, R Montironi, PR Carroll, M Wirth, MO Grimm, ... European urology 60 (2), 291-303, 2011 | 378 | 2011 |
| Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy SJ Freedland, ME Sutter, F Dorey, WJ Aronson Urology 61 (2), 365-369, 2003 | 371 | 2003 |